Standing Order
Moderna, Inc.

Dashboard

Moderna, Inc.

MRNANASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$79B
Price$195.0052w $22.36 – $269.00
Conviction3/ 5
Revenue (TTM)$2.5B
Revenue growth YoY+13.7%
P/E (trailing)—
Gross margin28.0%
Operating margin-116.0%
Net margin-110.5%
52w price change+620.9%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 18
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Nov 16
    DealSEC

    8-K filed with items 1.01 and 2.03 covering entry into material definitive agreement and creation of direct financial obligation.

  • Nov 13
    LeadershipSEC

    8-K reports item 5.02 officer or director change with exhibits.

  • Nov 9
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Nov 6
    Financial resultsSEC

    Moderna files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Oct 16
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Oct 7
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 30
    LeadershipSEC

    8-K filing (items 5.02, 7.01, 9.01) disclosing officer departure or appointment and related exhibits.

  • Sep 16
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 14
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 8
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 8
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 3
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 3
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 3
    Ownership changeSEC

    SEC Form 4 insider transaction filing reported for Moderna, Inc.

  • Sep 1
    OtherSEC

    Moderna 8-K filed with items 1.01, 2.03, 3.02, 8.01, 9.01 covering material agreements and equity securities.

  • Aug 31
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Aug 31
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Aug 31
    Ownership changeSEC

    Form 4 insider transaction filing reported.

  • Aug 7
    Ownership changeSEC

    SEC Form 4 filing reporting insider ownership change for MRNA.

Not financial advice — research and opinion only. Disclosures